Carlsson Research Selects Spotfire Analytical Platform.Business/Technology Editors CAMBRIDGE, Mass. and GOTEBORG, Sweden--(BUSINESS WIRE)--April 2, 2001 - Biotechnology Company Based on Nobel Price Winning Research Implements Spotfire Analytical Platform Throughout Research and Development- Spotfire(R) today announced that Spotfire DecisionSite(TM) is being adopted as the analytical platform for decision makers throughout research and development at Carlsson Research. "Spotfire's analytic platform is a very good match with Carlsson Research's method for drug discovery and development, known as Integrative Screening Process (ISP (1) See in-system programmable. (2) (Internet Service Provider) An organization that provides access to the Internet. Connection to the user is provided via dial-up, ISDN, cable, DSL and T1/T3 lines. ). ISP is a unique approach to investigating drug effects by means of multivariate data analysis," said Dr. Peder Svensson, Assistant Director at Carlsson Research. "We have a great deal of experience in working with Spotfire's products and are excited to expand the relationship." "Spotfire is proud to be associated with Carlsson Research, one of the thought leaders in biotechnology," said Dr. Christopher Dr. John R. Christopher, known popularly as "Dr. Christopher" was one of very few nationally prominent doctors of herbal medicine of the middle third of the 20th century, a "dark ages" of herbalism and was responsible for the herbal renaissance of the 1960s. Ahlberg, CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Spotfire. "Carlsson has combined its own unique method for drug development with the deployment of leading information solutions, such as Spotfire, to distinguish itself in the biotechnology market." About Spotfire(R) Spotfire, Inc. is a leading provider of eAnalytic applications and services that put the power of decision-making at the center of its customers' businesses. Spotfire's solutions enable organizations around the world to improve the efficiency, the speed and the accuracy of their decision-making processes Presented below is a list of topics on decision-making and decision-making processes: | width="" align="left" valign="top" |
| width="" align="left" valign="top" | About Carlsson Research Carlsson Research is devoted to the discovery and clinical development of new pharmacological treatment principles for psychiatric and neurological disorders This is a list of major and frequently observed neurological disorders (e.g. Alzheimer's disease), symptoms (e.g.back pain), signs (e.g. aphasia) and syndromes (e.g. Aicardi syndrome). . Carlsson Research was formed in 1998 in Gothenburg (Goteborg) on the western shores of Sweden. The company lends its name from CEO Arvid Carlsson Arvid Carlsson (b. January 25, 1923) is a Swedish scientist who is best known for his work with the neurotransmitter dopamine and its effects in Parkinson's disease. Carlsson won the Nobel Prize in Physiology or Medicine in 2000 along with co-recipients Eric Kandel and Paul , Emeritus Professor of Pharmacology and legendary neuroscientist neuroscientist A researcher, often with an advanced degree–MD, MS, PhD–who investigates neural and brain-related phenomena at the University of Goteborg. Arvid Carlsson was awarded the Nobel Prize in Physiology or Medicine Below is a list of the winners of the Nobel Prize in Physiology or Medicine (Swedish: Nobelpriset i fysiologi eller medicin) from 1901 to the present.[1] for 2000. Additional information can found at www.carlssonresearch.se and www.nobel.se Spotfire is a registered trademark and DecisionSite is a trademark of Spotfire, Inc. All other names or marks may be registered trademarks or trademarks of their respective owners and are hereby acknowledged. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion